FDA Webview Site FDA Review Site FDA Updater Site
header.gif
Username:
Password:
 

human drugs
animal drugs
biologics
eirs 483s
medical devices
marketing
email
search our site
  
FDA-RELATED NEWS
 
 
 
TXT Good Riddance to Kathleen Sebelius [364 Words]
04/10/2014
 
 
TXT Temple Promoting ‘Large, Simple Trials’ [396 Words]
04/10/2014
 
 
TXT Hamburg Wants Leveraged Science to Address Disease [340 Words]
04/09/2014
 
 
TXT FDA Hits Hospira with Another Warning Letter [404 Words]
04/08/2014
 
 
TXT Prof Defends Prohibition on Off-label Promotion [486 Words]
04/08/2014
 
 
TXT Firms Ask Court to Resolve Generic Preemption [412 Words]
04/08/2014
 
 
TXT HHS Seeks Comment on Health IT Strategy [500 Words]
04/03/2014
 
 
TXT Prescription Drug Spending Up Slightly in 2013 [308 Words]
04/09/2014
 
 
TXT Since Our Last Issue ... [447 Words]
04/13/2014
 
 
TXT Latest Federal Register Notices [1975 Words]
04/13/2014
 
 
TXT Product Approval Summaries [577 Words]
04/13/2014
 
 
TXT REMS Too Complex and Burdensome: PhRMA [174 Words]
04/11/2014
 
 
TXT How to Survive a Compliance Audit: Medtronic Official [338 Words]
04/11/2014
 
 
TXT FDA Class 1 Recall for Abbott Glucose Meters [96 Words]
04/11/2014
 
 
TXT Committee to Look at OTC Singulair [232 Words]
04/10/2014
 
 
TXT FDA Seeks Input on Regulating Health IT Products; Workshop Planned [437 Words]
04/10/2014
 
 
TXT Forest Opens DTC Awareness Campaign for Linzess [299 Words]
04/10/2014
 
 
TXT Gilead Asks for Stribild Exclusivity Reconsideration [366 Words]
04/10/2014
 
 
TXT FDA Phasing Out Some Codes for Medical Devices [338 Words]
04/09/2014
 
 
TXT GPhA, EGA Seek ‘Regulatory Convergence’ [651 Words]
04/09/2014
 
 
TXT Alzheimer Drug Guidance May Hurt Research: Author [360 Words]
04/09/2014
 
 
TXT FDA Wants More Info on Aclidinium/Formoterol Combo [205 Words]
04/09/2014
 
 
TXT Draft Guidance on Heparin Immunogenicity Considerations [98 Words]
04/08/2014
 
 
TXT Latest FDA Warning Letters [218 Words]
04/08/2014
 
 
TXT Companies Suggest Rare Diseases Approach Improvements [557 Words]
04/08/2014
 
 
TXT Allergan Asks Clinical Trials for Generic Restasis [433 Words]
04/08/2014
 
 
TXT Litigate or Settle? JAMS Experts Caution Healthcare Sector [325 Words]
04/08/2014
 
 
TXT Medtronic Infuse Case Sees Summary Judgment Before Preemption [160 Words]
04/07/2014
 
 
 
 
The most authoritative FDA news analysis each week is found in the pages of Dickinson's FDA Review. Since 1984, this newsletter has been providing in-depth reports on the most significant FDA developments affecting the pharmaceutical, medical device, biologics and veterinary medicines industries. Unlike other media, FDA Review eliminates time-wasting minutia and presents in clear, concise language the essence of what's really important - and why. It is the publication that FDA officials themselves read. Delivered in the middle of each week, FDA Review presents:
  • The latest agency policy developments, often before they're officially announced;
  • Major news insights, follow-ups and reactions in each product area;
  • Summaries of the latest Warning Letters;
  • The newest product approvals;
  • Summaries of the latest FDA Federal Register notices;
  • Summaries of DDMAC letters;
  • Related industry news capsules;
  • The industry's most concise FDA news index;
  • Inside-FDA news briefs
You can rely on FDA Review to provide only what's important - in the most convenient and time-saving